Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita
Clinical trial NCT03920228 · COMPLETED
Trial details
- NCT number
- NCT03920228
- Sponsor
- Palvella Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-09-19
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.